Mangoceuticals Inc

mangorx.com

What Do They Do?

Sells men’s wellness products and connects consumers with licensed healthcare professionals for telehealth care, including treatments for sexual health, hair loss and weight management.

How Do They Make Money?

Customers buy products and telehealth consultations directly through the company’s websites. Product sales are completed when products are handed to a carrier, while consultation services are provided over a period that is typically a few days.

FY2025 revenue

Who Are Their Customers?

Consumers buy products and services directly through the company’s websites, which connect them with licensed healthcare professionals and a pharmacy for online fulfillment.

Do Revenues Turn Into Profits?

No. It lost $20.6M in FY2025.

Operating income, FY2025

−3954% of revenue

▲ +126% (Loss) vs FY2024 (−$8M, −1294%)

Net income, FY2025

−4527% of revenue

▲ +137% (Loss) vs FY2024 (−$8.7M, −1414%)

How Are They Changing?

Since the FY2025 annual report

Latest quarter: Q2 FY2026, the three months to Jun 30, 2026

Revenue: ▼ −59%; vs $168.1K in Q2 FY2025
Net income: ▼ −76% (Loss); vs −$5.4M in Q2 FY2025

Aug 21, 2026 Terminated the business combination agreement with Nuclea Energy The parties mutually ended the agreement after the required minimum PIPE financing could not be raised by the outside date.
Jul 30, 2026 Agreed to combine with Nuclea Energy The proposed transaction would bring Nuclea into the company and called for Josef Freundorfer to become CEO and Jacob Cohen to become president.

Who Do They Compete With?

Competes with Hims & Hers Health, Roman, Pfizer, Lilly ICOS, Eli Lilly and, ICOS, Merck, and Johnson & Johnson

Comments